Development of a new calcilytic for the treatment of inflammatory lung disease
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa1060
Abstract: Background: Inhibitors of the extracellular calcium-sensing receptor (CaSR), termed calcilytics, were developed to evoke pulsatile changes in plasma parathyroid hormone (PTH) levels as a novel anti-osteoporotic treatment. Recently we have shown that they can suppress… read more here.
Keywords: inflammatory lung; new calcilytic; treatment inflammatory; treatment ... See more keywords